IDSA GUIDELINES Bundle (free trial)

Candida

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/635106

Contents of this Issue

Navigation

Page 13 of 17

12 Management XVI. Oropharyngeal Candidiasis Î For mild disease, clotrimazole troches, 10 mg 5 times daily, OR miconazole mucoadhesive buccal 50 mg tablet applied to the mucosal surface over the canine fossa once daily for 7-14 days are recommended (S/H). Î Alternatives for mild disease include nystatin suspension, (100,000 U/mL) 4-6 mL 4 times daily, OR 1-2 nystatin pastilles, (200,000 U each) 4 times daily, for 7-14 days (S/M). Î For moderate to severe disease, oral fluconazole, 100-200 mg daily, for 7-14 days is recommended (S/H). Î For fluconazole-refractory disease, itraconazole solution, 200 mg once daily OR posaconazole suspension, 400 mg twice daily for 3 days then 400 mg daily, for ≤28 days is recommended (S/M). Î Alternatives for fluconazole-refractory disease include voriconazole, 200 mg twice daily, OR AmB deoxycholate oral suspension, 100 mg/mL 4 times daily (S/M). Î Intravenous echinocandin (caspofungin, 70 mg loading dose, then 50 mg daily, micafungin 100 mg daily, or anidulafungin, 200 mg loading dose, then 100 mg daily) OR intravenous AmB deoxycholate, 0.3 mg/kg daily, are other alternatives for refractory disease (W/M). Î Chronic suppressive therapy is usually unnecessary. If required for patients who have recurrent infection, fluconazole, 100 mg 3 times weekly, is recommended (S/H). Î For HIV-infected patients, antiretroviral therapy is strongly recommended to reduce the incidence of recurrent infections (S/H). Î For denture-related candidiasis, disinfection of the denture, in addition to antifungal therapy, is recommended (S/M). XVII. Esophageal Candidiasis Î Systemic antifungal therapy is always required. A diagnostic trial of antifungal therapy is appropriate before performing an endoscopic examination (S/H). Î Oral fluconazole, 200-400 mg (3-6 mg/kg) daily, for 14-21 days is recommended (S/H). Î For patients who cannot tolerate oral therapy: Intravenous fluconazole, 400 mg (6 mg/kg) daily, OR an echinocandin (micafungin, 150 mg daily, caspofungin, 70 mg loading dose, then 50 mg daily, or anidulafungin, 200 mg daily) is recommended (S/H).

Articles in this issue

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Candida